Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer
Clinical trial NCT03124433 · COMPLETED
Trial details
- NCT number
- NCT03124433
- Sponsor
- Singapore General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2019-08-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.